Convergys (CVG) Tops Q4 EPS by 6c, Offers FY16 Outlook

Convergys (NYSE: CVG) reported Q4 EPS of $0.53, $0.06 better than the analyst estimate of $0.47. Revenue for the quarter came in at $751.8 million versus the consensus estimate of $754.02 million.

2016 Business Outlook

Convergys expects volume increases with several existing and new clients to more than offset volume fluctuations with a few clients in 2016. As a result, the company’s expectations for revenue, EBITDA and EPS include:

• Constant currency revenue growth to approximate 1 percent;
• Adjusted EBITDA margin to approximate 13 percent;
• Adjusted effective tax rate to approximate 21 percent;
• Diluted shares outstanding to approximate 104 million;
• Adjusted EPS growth of 5 percent to 8 percent.

For earnings history and earnings-related data on Convergys (CVG) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
• Skechers USA (SKX) Tops Q1 EPS by 23c, Beats on Revenue; Offers FY24 Guidance